In the last decades, bronchial asthma has represented a main focus of both basic and pharmacological research. In fact, the knowledge about pathophysiological mechanisms and phenotypes as well as the treatment opportunities have substantially increased1. In particular, the introduction of biologic drugs for severe asthma is leading a revolution in terms of pharmacological therapy, by paving the way to the precision medicine approach1
Titolo: | Uncontrolled severe asthma: starting from the unmet needs |
Autori: | |
Data di pubblicazione: | 2019 |
Rivista: | |
Handle: | http://hdl.handle.net/11562/995005 |
Appare nelle tipologie: | 01.01 Articolo in Rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.